S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
Log in
NASDAQ:AMTX

Aemetis Competitors

$9.83
-0.07 (-0.71 %)
(As of 02/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$8.59
Now: $9.83
$9.88
50-Day Range
$2.96
MA: $6.37
$9.90
52-Week Range
$0.37
Now: $9.83
$11.00
Volume1.42 million shs
Average Volume4.09 million shs
Market Capitalization$214.45 million
P/E RatioN/A
Dividend YieldN/A
Beta0.09

Competitors

Aemetis (NASDAQ:AMTX) Vs. LYB, IFF, WLK, BAK, NEU, and SXT

Should you be buying AMTX stock or one of its competitors? Companies in the industry of "industrial organic chemicals" are considered alternatives and competitors to Aemetis, including LyondellBasell Industries (LYB), International Flavors & Fragrances (IFF), Westlake Chemical (WLK), Braskem (BAK), NewMarket (NEU), and Sensient Technologies (SXT).

Aemetis (NASDAQ:AMTX) and LyondellBasell Industries (NYSE:LYB) are both oils/energy companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation.

Insider & Institutional Ownership

12.9% of Aemetis shares are held by institutional investors. Comparatively, 67.6% of LyondellBasell Industries shares are held by institutional investors. 28.3% of Aemetis shares are held by insiders. Comparatively, 0.2% of LyondellBasell Industries shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current ratings and price targets for Aemetis and LyondellBasell Industries, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Aemetis00103.00
LyondellBasell Industries213902.29

LyondellBasell Industries has a consensus price target of $76.4091, suggesting a potential downside of 25.88%. Given Aemetis' stronger consensus rating and higher probable upside, research analysts clearly believe Aemetis is more favorable than LyondellBasell Industries.

Earnings & Valuation

This table compares Aemetis and LyondellBasell Industries' top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aemetis$202 million1.06$-35,720,000.00($1.75)-5.62
LyondellBasell Industries$34.73 billion0.99$3.40 billion$9.6210.72

LyondellBasell Industries has higher revenue and earnings than Aemetis. Aemetis is trading at a lower price-to-earnings ratio than LyondellBasell Industries, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

Aemetis has a beta of 0.09, meaning that its share price is 91% less volatile than the S&P 500. Comparatively, LyondellBasell Industries has a beta of 1.55, meaning that its share price is 55% more volatile than the S&P 500.

Profitability

This table compares Aemetis and LyondellBasell Industries' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Aemetis-15.97%N/A-25.71%
LyondellBasell Industries4.23%24.09%5.80%

Summary

LyondellBasell Industries beats Aemetis on 10 of the 14 factors compared between the two stocks.

Aemetis (NASDAQ:AMTX) and International Flavors & Fragrances (NYSE:IFF) are both oils/energy companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation.

Insider & Institutional Ownership

12.9% of Aemetis shares are held by institutional investors. Comparatively, 94.4% of International Flavors & Fragrances shares are held by institutional investors. 28.3% of Aemetis shares are held by insiders. Comparatively, 0.4% of International Flavors & Fragrances shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current ratings and price targets for Aemetis and International Flavors & Fragrances, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Aemetis00103.00
International Flavors & Fragrances04802.67

International Flavors & Fragrances has a consensus price target of $141.1167, suggesting a potential upside of 4.14%. Given International Flavors & Fragrances' higher probable upside, analysts clearly believe International Flavors & Fragrances is more favorable than Aemetis.

Earnings & Valuation

This table compares Aemetis and International Flavors & Fragrances' top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aemetis$202 million1.06$-35,720,000.00($1.75)-5.62
International Flavors & Fragrances$5.14 billion2.82$455.87 million$6.1721.96

International Flavors & Fragrances has higher revenue and earnings than Aemetis. Aemetis is trading at a lower price-to-earnings ratio than International Flavors & Fragrances, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

Aemetis has a beta of 0.09, meaning that its share price is 91% less volatile than the S&P 500. Comparatively, International Flavors & Fragrances has a beta of 0.97, meaning that its share price is 3% less volatile than the S&P 500.

Profitability

This table compares Aemetis and International Flavors & Fragrances' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Aemetis-15.97%N/A-25.71%
International Flavors & Fragrances7.44%11.00%5.10%

Summary

International Flavors & Fragrances beats Aemetis on 12 of the 14 factors compared between the two stocks.

Aemetis (NASDAQ:AMTX) and Westlake Chemical (NYSE:WLK) are both oils/energy companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation.

Insider & Institutional Ownership

12.9% of Aemetis shares are held by institutional investors. Comparatively, 28.2% of Westlake Chemical shares are held by institutional investors. 28.3% of Aemetis shares are held by insiders. Comparatively, 73.1% of Westlake Chemical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current ratings and price targets for Aemetis and Westlake Chemical, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Aemetis00103.00
Westlake Chemical39402.06

Westlake Chemical has a consensus price target of $69.5333, suggesting a potential downside of 18.76%. Given Aemetis' stronger consensus rating and higher probable upside, research analysts clearly believe Aemetis is more favorable than Westlake Chemical.

Earnings & Valuation

This table compares Aemetis and Westlake Chemical's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aemetis$202 million1.06$-35,720,000.00($1.75)-5.62
Westlake Chemical$8.12 billion1.35$421 million$3.2626.25

Westlake Chemical has higher revenue and earnings than Aemetis. Aemetis is trading at a lower price-to-earnings ratio than Westlake Chemical, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

Aemetis has a beta of 0.09, meaning that its share price is 91% less volatile than the S&P 500. Comparatively, Westlake Chemical has a beta of 1.62, meaning that its share price is 62% more volatile than the S&P 500.

Profitability

This table compares Aemetis and Westlake Chemical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Aemetis-15.97%N/A-25.71%
Westlake Chemical5.14%4.74%2.25%

Summary

Westlake Chemical beats Aemetis on 12 of the 14 factors compared between the two stocks.

Aemetis (NASDAQ:AMTX) and Braskem (NYSE:BAK) are both oils/energy companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation.

Insider & Institutional Ownership

12.9% of Aemetis shares are held by institutional investors. Comparatively, 0.5% of Braskem shares are held by institutional investors. 28.3% of Aemetis shares are held by insiders. Comparatively, 0.0% of Braskem shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current ratings and price targets for Aemetis and Braskem, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Aemetis00103.00
Braskem02302.60

Braskem has a consensus price target of $14.00, suggesting a potential upside of 24.44%. Given Braskem's higher probable upside, analysts clearly believe Braskem is more favorable than Aemetis.

Earnings & Valuation

This table compares Aemetis and Braskem's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aemetis$202 million1.06$-35,720,000.00($1.75)-5.62
Braskem$12.72 billion0.35$-643,890,000.00($1.71)-6.58

Aemetis has higher earnings, but lower revenue than Braskem. Braskem is trading at a lower price-to-earnings ratio than Aemetis, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

Aemetis has a beta of 0.09, meaning that its share price is 91% less volatile than the S&P 500. Comparatively, Braskem has a beta of 1.36, meaning that its share price is 36% more volatile than the S&P 500.

Profitability

This table compares Aemetis and Braskem's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Aemetis-15.97%N/A-25.71%
Braskem-20.56%-962.43%-13.59%

Aemetis (NASDAQ:AMTX) and NewMarket (NYSE:NEU) are both oils/energy companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation.

Insider & Institutional Ownership

12.9% of Aemetis shares are held by institutional investors. Comparatively, 55.7% of NewMarket shares are held by institutional investors. 28.3% of Aemetis shares are held by insiders. Comparatively, 16.9% of NewMarket shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current ratings and price targets for Aemetis and NewMarket, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Aemetis00103.00
NewMarket0000N/A

Given Aemetis' higher probable upside, research analysts clearly believe Aemetis is more favorable than NewMarket.

Earnings & Valuation

This table compares Aemetis and NewMarket's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aemetis$202 million1.06$-35,720,000.00($1.75)-5.62
NewMarket$2.19 billion1.89$254.29 millionN/AN/A

NewMarket has higher revenue and earnings than Aemetis.

Volatility & Risk

Aemetis has a beta of 0.09, meaning that its share price is 91% less volatile than the S&P 500. Comparatively, NewMarket has a beta of 0.41, meaning that its share price is 59% less volatile than the S&P 500.

Profitability

This table compares Aemetis and NewMarket's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Aemetis-15.97%N/A-25.71%
NewMarket12.58%37.86%13.54%

Summary

NewMarket beats Aemetis on 9 of the 12 factors compared between the two stocks.

Aemetis (NASDAQ:AMTX) and Sensient Technologies (NYSE:SXT) are both oils/energy companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation.

Earnings & Valuation

This table compares Aemetis and Sensient Technologies' top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aemetis$202 million1.06$-35,720,000.00($1.75)-5.62
Sensient Technologies$1.32 billion2.50$82.05 million$2.9626.30

Sensient Technologies has higher revenue and earnings than Aemetis. Aemetis is trading at a lower price-to-earnings ratio than Sensient Technologies, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of current ratings and price targets for Aemetis and Sensient Technologies, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Aemetis00103.00
Sensient Technologies00103.00

Sensient Technologies has a consensus price target of $70.00, suggesting a potential downside of 10.08%. Given Aemetis' higher probable upside, research analysts clearly believe Aemetis is more favorable than Sensient Technologies.

Insider & Institutional Ownership

12.9% of Aemetis shares are held by institutional investors. Comparatively, 88.9% of Sensient Technologies shares are held by institutional investors. 28.3% of Aemetis shares are held by insiders. Comparatively, 0.8% of Sensient Technologies shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Aemetis and Sensient Technologies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Aemetis-15.97%N/A-25.71%
Sensient Technologies5.12%13.65%6.97%

Volatility & Risk

Aemetis has a beta of 0.09, meaning that its share price is 91% less volatile than the S&P 500. Comparatively, Sensient Technologies has a beta of 0.96, meaning that its share price is 4% less volatile than the S&P 500.

Summary

Sensient Technologies beats Aemetis on 10 of the 12 factors compared between the two stocks.


Aemetis Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
LyondellBasell Industries logo
LYB
LyondellBasell Industries
2.5$103.09-1.3%$34.42 billion$34.73 billion29.29Dividend Announcement
Insider Selling
Analyst Revision
News Coverage
International Flavors & Fragrances logo
IFF
International Flavors & Fragrances
2.3$135.51-0.8%$14.49 billion$5.14 billion40.57Decrease in Short Interest
Westlake Chemical logo
WLK
Westlake Chemical
2.4$85.59-0.0%$10.93 billion$8.12 billion28.34Earnings Announcement
Dividend Announcement
Analyst Upgrade
Insider Selling
Analyst Revision
News Coverage
Braskem logo
BAK
Braskem
1.1$11.25-3.8%$4.48 billion$12.72 billion-1.98Analyst Upgrade
Gap Down
NewMarket logo
NEU
NewMarket
1.0$378.98-2.0%$4.14 billion$2.19 billion16.50Dividend Announcement
News Coverage
Sensient Technologies logo
SXT
Sensient Technologies
1.8$77.85-0.4%$3.30 billion$1.32 billion48.96Decrease in Short Interest
Amyris logo
AMRS
Amyris
1.1$13.80-0.1%$3.30 billion$152.56 million-6.19Upcoming Earnings
Analyst Report
Gap Down
Renewable Energy Group logo
REGI
Renewable Energy Group
1.8$77.77-10.5%$3.06 billion$2.64 billion5.62Earnings Announcement
Analyst Report
Analyst Revision
News Coverage
Gap Down
Methanex logo
MEOH
Methanex
1.6$38.54-1.7%$2.94 billion$2.78 billion-23.08Analyst Revision
News Coverage
Gevo logo
GEVO
Gevo
1.3$9.71-3.3%$1.50 billion$24.49 million-5.96Analyst Report
News Coverage
Gap Down
Codexis logo
CDXS
Codexis
1.1$22.11-3.9%$1.31 billion$68.46 million-63.17Earnings Announcement
Analyst Report
News Coverage
Green Plains logo
GPRE
Green Plains
1.2$25.32-4.3%$902.68 million$2.42 billion-8.92High Trading Volume
News Coverage
Gap Up
Westlake Chemical Partners logo
WLKP
Westlake Chemical Partners
1.7$23.51-2.8%$827.41 million$1.09 billion12.78Earnings Announcement
Analyst Report
High Trading Volume
Gap Down
FutureFuel logo
FF
FutureFuel
1.3$14.68-2.7%$642.15 million$205.23 million5.65Increase in Short Interest
Gap Down
REX American Resources logo
REX
REX American Resources
0.9$94.07-0.0%$563.67 million$418.03 million144.72Analyst Downgrade
News Coverage
Gap Up
Alto Ingredients logo
PEIX
Alto Ingredients
1.7$6.48-2.8%$443.85 million$1.42 billion-8.00
Green Plains Partners logo
GPP
Green Plains Partners
1.8$10.13-7.2%$235.10 million$82.39 million5.79High Trading Volume
Decrease in Short Interest
Gap Up
TOMZ
TOMI Environmental Solutions
0.0$4.24-4.5%$71.07 million$6.35 million0.00Upcoming Earnings
Increase in Short Interest
Gap Down
TANH
Tantech
0.6$1.58-4.4%$56.71 million$49.23 million0.00Gap Down
CYTH
Cyclo Therapeutics
1.8$8.35-2.8%$14.20 million$1.01 million0.00
This page was last updated on 2/28/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.